The Role of Digital Health Technologies in Drug Development Proceedings of a Workshop (2020) / Chapter Skim
Currently Skimming:
Appendix B: Workshop Agenda
Appendix B: Workshop Agenda
Pages 101-104
The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.
From page 101... ...
Robert Califf, Verily Life Sciences Geoffrey Ginsburg, Duke University School of Medicine Opening Remarks Jennifer Goldsack, Digital Medicine Society Joseph Menetski, Foundation for the National Institutes of Health Briefing: Ethical Considerations 10:15 a.m. Ethicist Perspective Camille Nebeker, University of California, San Diego Session I: Digital Tools for Characterizing Disease Effy Vayena, Health Ethics and Policy Lab, ETH Zurich, Moderator 10:45 a.m.
|
From page 102... ...
Food and Drug Administration Industry Perspective Yvonne Yu-Feng Chan, Otsuka Pharmaceutical Developer Perspective Chris Benko, Koneksa Health Academic Perspective Eric Perakslis, Duke University 12:40 p.m. Panel Discussion with Speakers and Workshop Participants 1:00 p.m.
|
From page 103... ...
Patient Engagement Perspective Sally Okun, UnitedHealth Group Research & Development Clinician/Health System Perspective Edmondo Robinson, Moffitt Cancer Center 3:30 p.m. Panel Discussion with Speakers and Workshop Participants Key Reflections and Next Steps 3:45 p.m.
|
Key Terms
This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More
information on Chapter Skim is available.